Pharma customers serving the biologics market require smaller manufacturing runs as these markets have a smaller subset of patients. As a result, contract partners must be able to provide Ready-To-Use (RTU) products that allow for faster and more flexible runs.
Aptar Pharma fulfills this request for customer by providing RTU stoppers. The stoppers, along with vials, and seals are available through Aptar’s QuickStart® for Injectables, a one-stop-shop, ready-to-use sterile solution, designed specifically to accelerate the development time for start-ups and early-stage development, R&D, biotechs, and university research organizations.
Publications, Pharmaceutical
Aptar Pharma’s Ready-to-Use Program Facilitates Development Times
Pharma customers serving the biologics market require smaller manufacturing runs as these markets have a smaller subset of patients. As a result, contract partners must be able to provide Ready-To-Use (RTU) products that allow for faster and more flexible runs.
Author(s):
Adam Shain
Drug Development & Delivery
1
May
2019
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
Related Articles
Request Access
Close
Requesting access to Aptar Pharma’s Ready-to-Use Program Facilitates Development Times.
How Can We Help?
